APGE

Apogee Therapeutics, Inc.

50.10 USD
+0.72 (+1.46%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Fundamentals

Fundamental data refers to the information about the company itself, its financial state, sales and revenues, profitability and growth. This is a set of metrics used by financial analysts to gauge the financial health of an organization as well as its future prospects. This page will include information about many of the common fundamental metrics and KPIs used to evaluate and price the value of public corporations in the United States and around the world.

Price to Earnings Ratio (ttm) 

-21.1

Price to Book Value 

7.3

Operating Expenses 

-38.18M USD

Net Income 

-32.09M USD

Earnings Per Share, Basic 

-0.64 USD

Earnings Per Share, Diluted 

-0.64 USD

EBITDA 

-38.15M USD

Shares (Basic) 

50,189,808.00

Shares (Diluted) 

50,189,808.00

Market-Cap 

0.00 USD

Enterprise Value 

0.00 USD

Price to Sales Ratio (ttm) 

0.0

EV/EBITDA 

0.0

Revenue 

0.00 USD

Cost of Revenue 

0.00 USD

Gross Profit 

0.00 USD